How Psma Revolutionizes Staging For

The sensitivity and specificity of the

Robert E. Reiter, MD, Bing Professor of Urology and Molecular Biology, Director of the Prostate Cancer Program, and Director of ...

The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion Webcast (2025) ...

The 2022 Prostate Cancer Patient Conference is Sept 10-11, 2022! RSVP Today! https://pcri.org/2022-conference Alex asks ...

Steven Rowe, MD, PhD, gives an overview of current data on prostate-specific membrane antigen (

Presented By: Ephraim Parent, M.D., PhD Speaker Biography: Ephraim Parent MD, PhD is an associate professor of Radiology at ...

Emerging evidence on the role of prostate-specific membrane antigen in the development and growth of prostate cancer has ...

An interview with Preston Sprenkle, MD, Associate Professor of Urology at Yale; Chief of Urology at the VA Connecticut ...

Next Generation Imaging (

Jérémie Calais, MD, MSc, discusses the superior imaging offered by

Lutetium-177 (known by the trade name "Pluvicto" in the United States) was FDA-approved in 2022 for the treatment of men with ...

To learn more about the top medical innovations for 2022, please visit https://cle.clinic/3GPe1c9 Each year, more than 200000 ...

Donate to PCRI: https://pcri.org/donate For more information. visit www.pcri.org 0:48 What is a

Adam B. Murphy, MD, discusses the Stockholm3 blood test, which determines prostate cancer risk and may help reduce ...

Discover the miracle of

Steven P. Rowe, MD, PhD, explains research supporting the emerging role of

Next Generation Imaging (

For the latest updates on theranostic imaging in prostate cancer, join our community: ...

Gleason 4+4=8 (Epstein Grade Group 4) is the lowest Gleason score that is considered "high-risk prostate cancer." Despite the ...

This is part 2 of the revolution in prostate cancer imaging and management, unless you live in Ontario. I hope you find this both as ...